
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
After three years of waiting Shire’s Firazyr has been approved by the FDA for sudden attacks of swelling. The US …
Bayer’s Factor Xa anticoagulant Xarelto scooped the Best Pharmaceutical Agent award at the prestigious Prix Galien ceremony. Xarelto is part …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

